Schroder Investment Management Group Blueprint Medicines Corp Transaction History
Schroder Investment Management Group
- $101 Billion
- Q4 2024
A detailed history of Schroder Investment Management Group transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Schroder Investment Management Group holds 38,434 shares of BPMC stock, worth $3.55 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,434
Previous 96,299
60.09%
Holding current value
$3.55 Million
Previous $8.9 Million
62.35%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding BPMC
# of Institutions
380Shares Held
65.9MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$625 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$613 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$524 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA4.28MShares$395 Million0.07% of portfolio
-
State Street Corp Boston, MA2.5MShares$231 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.51B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...